Evidence map›Paper›PMID 31143211›Full record

ReviewTanaffos2018

Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies.

Mohammad-Foad Noorbakhsh, Hanieh Shaterzadeh-Yazdi, Farzad Hayati, Saeed Samarghandian, Tahereh Farkhondeh

Open access · greenAbstract readReview
PubMed Full text at PMC
In one paragraph

Review in Tanaffos, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Potential Pharmacological Applications ofPlants (Basel, Switzerland) · 2023
    Review
  4. Black Cumin (Nutrients · 2021
    Review
  5. Article
  6. Bioscience reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mohammad-Foad NoorbakhshDivision of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Hanieh Shaterzadeh-YazdiResearch Center of Pardis Hospital, Mashhad, Iran.
Farzad HayatiResearch Center of Pardis Hospital, Mashhad, Iran.
Saeed SamarghandianNoncommunicable Disease Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.
Tahereh FarkhondehCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Birjand University of Medical Sciences · IRShiraz University · IRUniversity of Neyshabur · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung as vital organ is exposed to many injurious agents that can cause inflammation and oxidative stress, which are potential causes in the pathogenesis of lung diseases.

Indexed as

AsthmaLung cancerLung fibrosisLung inflammationThymoquinone

Identifiers

PMID31143211
PMCPMC6534803
OpenAlexW3015436202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.